Is AstraZeneca Pharma India stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, AstraZeneca Pharma India pays dividends. Last time was Friday 6th of September 2024 where the investors holding the stock on Friday 5th of July 2024 were paid INR24 per share. Over the last 17 times between 2003 and 2024, AstraZeneca Pharma India has paid INR208.1 with an average of INR12.24 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for AstraZeneca Pharma India 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR1 993.10, you would have made a profit of INR4 891.30 per share or 245.41%
Yes, the average daily trading liquidity for AstraZeneca Pharma India is INR29 656 thousand. You should therefore be able to get in and out of your positions relatively fast.
AstraZeneca Pharma India has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 5.38, the company's ability to pay off the debt is good. AstraZeneca Pharma India has a good net profit margin of 12.47% and should have high tolerances against inflation.
We have calculated the inflation risk for AstraZeneca Pharma India to be low [0.1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.